@article{1e24bd0cc69d4a1190f4f123d476d7cb,
title = "Validating chemoimmunotherapy in small-cell lung cancer",
author = "Smith, {Katherine E.R.} and Mansfield, {Aaron S.}",
note = "Funding Information: ASM reports research funding from the United States National Cancer Institute (R21 CA251923), Department of Defense, Mark Foundation, Novartis, and Verily; honoraria to institution for participation in advisory boards from AbbVie, AstraZeneca, BeiGene, BMS, Genentech, and Janssen; travel support and honoraria from Shanghai Roche; and is a non-remunerated member of the Mesothelioma Applied Research Foundation Board of Directors. KERS declares no competing interests.",
year = "2022",
month = jun,
doi = "10.1016/S1470-2045(22)00288-1",
language = "English (US)",
volume = "23",
pages = "692--693",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "6",
}